TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells

Seblewongel Asrat1, Joseph C Devlin1, Andrea Vecchione1

  • 1Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.

Cell Reports Methods
|August 3, 2023
PubMed
Summary

Researchers developed TRAPnSeq to profile antigen-specific antibody-secreting cells (ASCs) by capturing secreted antibodies. This method enables high-throughput screening for therapeutic antibody discovery.

Related Concept Videos